Efficacy and safety of a multifactor intervention to improve therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): Protocol for the ICEPOC study

Trials

Volumn 12, Issue , 2011, Pages

  Barnestein Fonseca, Pilar ^a   Leiva Fernández, José ^b   Vidal España, Francisca ^a   García Ruiz, Antonio ^c   Prados Torres, Daniel ^a   Leiva Fernández, Francisca ^a  

^a Family and Community Medicine Teaching Unit of Malaga   (Spain)

^b Velez Sur Health Centre   (Spain)

^c UNIVERSIDAD DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR CHANGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL PROTOCOL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; ATTITUDE TO HEALTH; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMOTION; HEALTH BEHAVIOR; METHODOLOGY; MOTIVATION; NEBULIZER; PATIENT EDUCATION; REINFORCEMENT; SPAIN; TREATMENT OUTCOME;

BRONCHODILATING AGENT;

ADMINISTRATION, INHALATION; BRONCHODILATOR AGENTS; COGNITION; EMOTIONS; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICATION ADHERENCE; MOTIVATION; NEBULIZERS AND VAPORIZERS; PATIENT EDUCATION AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REINFORCEMENT (PSYCHOLOGY); RESEARCH DESIGN; SPAIN; TREATMENT OUTCOME;

EID: 79851510092     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-40     Document Type: Article

References (35)

1. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004, 42:200-9. 10.1097/01.mlr.0000114908.90348.f9, 15076819.
2. World Health Organization Adherence to long-term therapies: policy of action. Meeting report 4-5 June 2001 (accessed may 2009), World Health Organization., http://www.who.int/chronic-conditions/adherence/en/
3. Rand CS, Nides M, Cowles MK, Wise RA, Connett J. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med 1995, 152:580-8.
4. Kesten S, Flanders J, Serby C. Compliance with tiotropium, a once daily dry powder inhaled bronchodilator, in one year COPD trials. Chest 2000, 118:191S-2.
5. van Grunsven PM, van Schayck CP, van Deuveren M, Herwaarden CL, Akkermans RP, van Weel C. Compliance during long term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma 2000, 37:225-34. 10.3109/02770900009055445, 10831147.
6. Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 2006, 118:899-904. 10.1016/j.jaci.2006.07.002, 17030244.
7. Breekveldt-Postma NS, Gerrits CM, Lammers JW, Raaijmakers JA, Herings RM. Persistence with inhaled corticosteroid therapy in daily practice. Respir Med 2004, 98:752-9. 10.1016/j.rmed.2004.01.014, 15303640.
8. Krigsman K, Nilsson JL, Ring L. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf 2007, 16:441-8. 10.1002/pds.1321, 17006959.
9. Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996, 109:963-68. 10.1378/chest.109.4.963, 8635378.
10. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner DD, Wilkins RL. Medication adherence issues in patients treated for COPD. Int J COPD 2008, 3:371-384.
11. Tashkin DP. Multiple dose regimens: Impact on compliance. Chest 1995, 107:176S-182S. 10.1378/chest.107.5_Supplement.176S, 7743823.
12. Bourbeaux J, Bartlett SJ. Patient adherence in COPD. Thorax 2008, 63:831-838. 10.1136/thx.2007.086041, 18728206.
13. Gallefoss F, Bakke P. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. Am J Respir Crit Care Med 1999, 160:2000-2005.
14. Gallefoss F, Bakke P, Kjaerrgaard P. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:812-817.
15. Worth H, Dhein Y. Does patient education modify behaviour in the management of COPD?. Patient Educ Couns 2004, 52:267-270. 10.1016/S0738-3991(03)00101-0, 14998596.
16. Hesselink AE, Penninx B, van der Windt D, van Duin BJ, de Vries P, Twisk JWR, Bouter LM, van Eijk JTM. Effectiveness of an education programme by a general practice assistant for asthma and COPD patients: results from a randomised controlled trial. Patient Educ Couns 2004, 55:121-128. 10.1016/j.pec.2003.08.007, 15476999.
17. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Intervenciones para mejorar la adherencia a la medicación (Revisión Cochrane traducida). La Biblioteca Cochrane Plus 2008, 2. Oxford: Update Software Ltd, (Translate fromThe Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd.)., http://www.update-software.com
18. George J, Kong D, Thoman R, Steward K. Factors associated with medication nonadherence in patients with COPD. Chest 2005, 128:3198-3204. 10.1378/chest.128.5.3198, 16304262.
19. Batalla A, Blanquer R, Ciurana M, García M, Jordi E, Pérez A. Cumplimiento de la prescripción farmacológica en pacientes hipertensos. Aten Primaria 1984, 1:185-91.
20. Morinsky DE, Green LW, Levine AM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 1:67-74.
21. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance?. Hypertension 1980, 2:757-764.
22. Leiva-Fernández F, Barnestein-Fonseca P, Vidal-España F, Leiva-Fernández J, García-Ruiz AJ, y Prados-Torres JD. Adecuación terapéutica de pacientes con EPOC en Atención Primaria ¿Es posible diagnosticar el cumplimiento terapéutico en la práctica clínica habitual?. Med Fam (Andal) 2008, 9:147-160.
23. Normativa SEPAR Espirometría forzada. (accessed may 2010)., http://www.separ.es/publicaciones/normativas_y_procedimientos.html
24. Sackett DL, Haynes RB, Gibson ES. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975, 1:1205-1207. 10.1016/S0140-6736(75)92192-3, 48832.
25. Piñeiro F, Gil V, Donis M, Orozco D, Pastor A, Merino J. Validez de 6 métodos indirectos para valorar el cumplimiento del tratamiento farmacológico en la hipertensión arterial. Aten Primaria 1997, 19(7):372-6.
26. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009, 43:413-22. 10.1345/aph.1L496, 19261962.
27. Ferrer M, Alonso J, Prieto L, Plaza V, Monso E, Marrades R, Aguar MC, Khalaf A, Antó JM. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J 1996, 9:1160-66. 10.1183/09031936.96.09061160, 8804932.
28. Herdman M, Badía X, Berra S. El EuroQoL-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en Atención Primaria. Aten Primaria 2001, 28:425-30.
29. Peces-Barba G, Barberá JA, Agustí A, Casanova C, Casas A, Izquierdo JL, Jardim J, López Varela V, Monsó E, Montemayor T, Viejo JL. Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Normativa SEPAR. Arch Bronconeumol 2008, 44:271-81. 10.1157/13119943, 18448019.
30. Bellón JA, Delgado A, Luna del Castillo J, Lardelli P. Validez y fiabilidad del cuestionario de función familiar Apgar-familiar. Aten Primaria 1996, 18:289-294.
31. Bellón JA, Delgado A, Luna del Castillo J, Lardelli P. Validez y fiabilidad del cuestionario de apoyo social funcional Duke-UNC-11. Aten Primaria 1996, 18:153-294161.
32. Murphy E, Dingwall R. Qualitative Methods and Health Policy Research 2003, New York: Aldine de Gruyter.
33. Brown JB. The use of focus groups in clinical research. Doing Qualitative Research 1999, 109-24. Thousand Oaks. CA: Sage, Crabtree BF, Miller WL.
34. Giner J, Basualdo LV, Casan P, Hernandez C, Macián V, Martinez I. Utilización de fármacos inhalados. Recomendaciones SEPAR. (accessed may 2010)., http://www.separ.es/publicaciones/normativas_y_procedimientos.html
35. Luque MJ. Eficacia de una intervención terapéutica multifactor sobre el exceso de peso en Atención Primaria. PhD thesis 2006, Málaga University, Pharmacology Department (UMA)/Family and Community Medicine Teaching Unit from Malaga (Health District Malaga).